Generic agents play a crucial role in reducing the cost of medical care in many countries.
However, the therapeutic equivalence remains a great concern. Our study aims to assess …

Bioequivalence of levofloxacin (CAS 100986-85-4) 500 mg tablets was assessed in a single
dose, open, randomised, crossover trial, with a minimum washout period of 7 days. Serum …

An improved HPLC method was developed and validated for the determination of
concentration of levofloxacin (CAS 100986-85-4) in human plasma. This paper is an attempt …

Counterfeit and substandard medicines are recognized as one of serious threats to public
health. The product quality of antibacterial medicine will compromise patients' recovery and …

This study was aimed at comparing the physicochemical and bioavailability profiles of some
brands of Levofloxacin 500mg tablets that are registered in Nigeria by her regulatory …

Objectives The efficacy and quality of generic antibacterial drug formulations are often
questioned by both healthcare specialists and patients. Therefore, the present study …

A high‐performance liquid chromatography method with fluorescence detection (HPLC‐
FLD) for the determination of levofloxacin in human plasma is described. Neutralized with …

This study aimed to determine the therapeutic equivalence of four multi-source drugs
containing moxifloxacin (400 mg tablets) in vitro studies to establish their interchangeability …

Background: Levofloxacin, a third generation fluoroquinolone and the L-isomer of the
racemate ofloxacin with improved antimicrobial activities. It is mostly prescribed and utilized …

Background: Levofloxacin is a synthetic fluoroquinolone with a broad spectrum of
antibacterial activity. It is indicated for the treatment of respiratory, sinus, skin, and urinary …